Table 1.

EBV in nasal NK/T-cell lymphoma

Source	Country	EBV positive rate (%)	EBV subtype	Expression of latent
[18]a	France	7/7 (100)	NA	7/7 LMP+
[20]	China	21/21 (100)	NA	5/21 LMP-1+
[21]	Japan	11/12 (92)	10/11 typeA	8/12 LMP-1+
[22]	Korea	15/16 (94)	15/15 typeA	7/15 LMP-1+
[24]	Indonesia	18/20 (90)	NA	NA

EBV Epstein–Barr virus, LMP latent membrane protein, NA not available

^aFresh tissue samples were used in the analyses